Skip to main content
Skip to footer
Evaluate Pathobiological and Clinical Significance of Tumor Immune Microenvironment in Multiple Myeloma (MM) and Therapy-Related Myelodysplastic Syndrome / Acute Myeloid Leukemia (t-MDS / t-AML)
- evaluate key immune cell subsets in formalin-fixed and paraffin-embedded (FFPE) archival myeloma bone marrow specimens
- temporal dynamics following disease progression and treatment (conventional chemotherapy, immune therapy)
- clinical outcome correlation
Diagnostic Development: Validation of Multiplex and Spatial Diagnostic Assays
- develop multiplex (10-plex) immunostaining assays as the next-generation of laboratory developed tests (LDTs) for FFPE specimens
- quantitative diagnostic reporting of immune cell subsets and relevant spatial relationships (PD1+ %, tumor to CD8+ T cell distance, neighborhood composition, intra-tumoral heterogeneity)
- we welcome opportunities to collaborate on immune biomarker correlative analysis for clinical trials